Drugs / FVIII
last change Sep 2012 re-read 3 minutes ago

FVIII

Protein / enzyme biologic

Developed for
hemophilia A
Investigated by
Hospices Civils de Lyon

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT00995046 Sep 2009 → Sep 2012 hemophilia A Hospices Civils de Lyon Terminated No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FVIII ClinicalTrials.gov intervention name — accepted as the source's own label NCT00995046 ↗
Modality Protein / enzyme biologic “prophylactic therapy was developed involving the infusion of clotting factor” NCT00995046 ↗